Recent advances in endometriosis

In: Current Opinion in Endocrinology and Diabetes · 1998 · vol. 5(4) , pp. 330–340 · doi:10.1097/00060793-199811000-00015 · W2321576802
article OA: closed CC0 ⤵ 18 in-corpus citations
Full text JSON View on OpenAlex View at publisher
AI-generated summary by claude@2026-06, 2026-06-12

Recent research indicates peritoneal fluid factors and differences between ectopic and eutopic endometrium contribute to endometriosis pathogenesis, affecting cell proliferation and patient outcomes.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

Recent research on the pathogenesis of endometriosis has provided more evidence that factors in peritoneal fluid (PF) may play a role in the progression of the disease. Examples of these factors are mterleukin (IL)-8. RANTES (regulated on activation, normal T cell expressed and secreted), IL-13, IL-10, and monocyte chemoattractant protein-1. These factors are associated with proliferation of endometrial cells, changes in the cytotoxicity of peritoneal macrophages, and the responsiveness of ectopic endometrium to cytolysis. Differences in the characteristics of the ectopic and eutopic endometnum, eg, aromatase expression, matrix metalloproteinases, apoptosis markers, and integrin expression have also been shown. The effect of endometriosis on reproductive outcome as well as its pathophysiologic mechanisms have been investigated. Treatment options for endometriosis-associated infertility or pelvic pain that give maximal pain relief and fertility outcome with fewer side effects have been evaluated. Resection or ablation of even minimal or mild lesions is now recommended for the treatment of endometnosis-associated infertility.
Full text 1,205 characters · extracted from oa-doi-fallback · click to expand
Recent advances in endometriosis - Aydin Arici - Tugce Pehlivan Recent research on the pathogenesis of endometriosis has provided more evidence that factors in peritoneal fluid (PF) may play a role in the progression of the disease. Examples of these factors are mterleukin (IL)-8. RANTES (regulated on activation, normal T cell expressed and secreted), IL-13, IL-10, and monocyte chemoattractant protein-1. These factors are associated with proliferation of endometrial cells, changes in the cytotoxicity of peritoneal macrophages, and the responsiveness of ectopic endometrium to cytolysis. Differences in the characteristics of the ectopic and eutopic endometnum, eg, aromatase expression, matrix metalloproteinases, apoptosis markers, and integrin expression have also been shown. The effect of endometriosis on reproductive outcome as well as its pathophysiologic mechanisms have been investigated. Treatment options for endometriosis-associated infertility or pelvic pain that give maximal pain relief and fertility outcome with fewer side effects have been evaluated. Resection or ablation of even minimal or mild lesions is now recommended for the treatment of endometnosis-associated infertility.

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

Ask this paper AI returns verbatim quotes from the full text · source: oa-doi-fallback

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Condition tags

endometriosisinfertility

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

Cited by (18)

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
unpaywall
last seen: 2026-08-05T06:45:03.150373+00:00
License: CC0 · commercial use OK